Tumor extracellular vesicles carrying antitumor (KLAKLAK)2 peptide and tumor-specific antigens for improved tumor therapy
Authors:
- 20 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 53 (4) , 505-516
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2021R1A2B5B01001932)
This publication has 34 references indexed in Scilit:
- Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapyActa Biomaterialia, 2018
- Enhancing Therapeutic Efficacy of Combined Cancer Phototherapy by Ultrasound‐Mediated In Situ Conversion of Near‐Infrared Cyanine/Porphyrin Microbubbles into NanoparticlesAdvanced Functional Materials, 2017
- Development of pH-responsive starch–glycol chitosan nanogels for proapoptotic (KLAKLAK)2 peptide deliveryJournal of Bioactive and Compatible Polymers, 2016
- Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor CellsNanomaterials, 2016
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyNature, 2016
- Bioresponsive Hyaluronic Acid‐Capped Mesoporous Silica Nanoparticles for Targeted Drug DeliveryChemistry – A European Journal, 2013
- Combination therapy: the next opportunity and challenge of medicineJournal of Translational Medicine, 2011
- Characterization of CD44-Mediated Cancer Cell Uptake and Intracellular Distribution of Hyaluronan-Grafted LiposomesMolecular Pharmaceutics, 2011
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Liposomal Formulations of Synthetic MUC1 Peptides: Effects of Encapsulation versus Surface Display of Peptides on Immune ResponsesBioconjugate Chemistry, 1998